A Randomized Study of the Relative Pharmacokinetics, Pharmacodynamics, and Safety of Alirocumab, a Fully Human Monoclonal Antibody to <scp>PCSK</scp>9, After Single Subcutaneous Administration at Three Different Injection Sites in Healthy Subjects

Abstract

These results suggest that alirocumab can be interchangeably injected in the abdomen, upper arm, or thigh.